Artelo Biosciences, Inc. (ARTL)

1,3000 -0,0800 (-5,80%) Börsenschluss: 04:00PM EDT

Artelo Biosciences, Inc.

505 Lomas Santa Fe
Suite 160
Solana Beach, CA 92075
United States
858 925 7049
https://www.artelobio.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 6

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Gregory D. Gorgas M.B.A.	President, CEO, CFO, Treasurer, Secretary & Director	742,45k	N/A	1963
Dr. Andrew Yates Ph.D.	Senior VP & Chief Scientific Officer	N/A	N/A	N/A
Dr. Steven D. Reich	Chief Medical Officer	N/A	N/A	1946
Mr. Jason H. Baybutt	Senior Vice President of Finance	N/A	N/A	1972

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.

Corporate Governance

Artelo Biosciences, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.